Navigation Links
Unilens Vision Reports Increased Royalty Income
Date:5/28/2008

21st Consecutive Profitable Quarter Earns $.08 Per Diluted Share

LARGO, Fla., May 28 /PRNewswire-FirstCall/ -- Unilens Vision Inc. (OTC Bulletin Board: UVICF) (TSX Venture Exchange: UVI), which develops, licenses, manufactures, distributes and markets specialty contact lenses, today reported its operating results for the third quarter and first nine months of FY2008.

Net sales, excluding royalty income, for the quarter ended March 31, 2008 increased to $1,668,397 compared with $1,634,429 in the prior-year quarter ending March 31, 2007 an increase of 2.1%. The increase was primarily the result of continued growth of the Company's C-Vue multifocal contact lenses, which increased approximately 11% in the current quarter, which was partially offset by sales of our replacement products lines that declined as expected.

Royalty income for the quarter increased 15.3% to $628,993 compared with $545,293 in the prior-year quarter. Sales of licensed products by our licensee Bausch & Lomb continue to increase, resulting in continued double digit royalty income growth.

For the quarter, the Company reported net income of $368,730, or $0.08 per diluted share, compared with net income of $372,355 or $0.08 per diluted share in the prior-year quarter.

For the nine months ended March 31, 2008, net sales excluding royalty income, increased 3.8% to $4,854,119 as compared to $4,677,358 for the prior- year period. Net sales of the Company's C-Vue multifocal contact lenses increased approximately 12% during the first nine months of fiscal year 2008, while sales of replacement products lines declined, as expected.

Net Income for the nine months increased 24.2% to $1,121,941, or $0.25 per diluted share, compared with $903,697, or $0.20 per diluted share in the prior-year period.

Royalty income for the nine months ended March 31, 2008 increased 21.1% to a record $1,888,641, compared with $1,559,496 in the prior-year period, demonstratin
'/>"/>

SOURCE Unilens Vision Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Unilens Launches Aspheric C-VUE(R) Daily Disposable Lens
2. Unilens Vision Inc. Declares Regular Quarterly Cash Dividend of U.S. $0.09 Per Share
3. Unilens Vision Reports 70% Increase in Second Quarter Earnings on Higher Sales and Record Royalty Income
4. Unilens Vision Inc. Declares Regular Quarterly Cash Dividend of U.S. $0.09 Per Share
5. Unilens Vision Reports Record First Quarter Earnings and Royalty Income
6. Unilens Names Eschenbach Optik Exclusive Worldwide Distributor of the UniVision(R) Low Vision Lens
7. IMTEC Introduces New Vision Software
8. Delray Beach Soccer Club Signs Division One College Soccer Coaches
9. Lutein and Zeaxanthin Improve Sports Vision for Athletes
10. World Vision Appealing for $2 Million for Deadly China Quake
11. AVMA Declares Preliminary Victory on Farm Bill Provisions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...-profit Launches Age-related Macular Degeneration ...igible Patients and Free Eye-Healthy Cookbooks , ...December 2, 2008 -- "Do You See What I See?&q...own as Age-related Macular Degeneration (AMD) the ... this…. a large black hole in the center of...
(Date:12/2/2008)... announces that the SouthEast Alaska Regional Heal...cted the Rhapsody™ Integration Engine to hel...y, pharmacy, laboratory and business programs comm...onnectivity to statewide systems such as VacTrAK (...IMS (an MIS and clinical documentation tool used b...
(Date:12/2/2008)...al Provides Online Resource and Fire Safety Tips f... Boston, MA (PRWEB) December 2, 2008... Peete , actress, philanthropist and mother of fou...de a few moments before the holiday rush to review...ireSmart.com. , , , , ,Home fires top the list of...
(Date:12/2/2008)...ire/ -- Population Services International (PSI) is...dramatically reduce the number of African children...rovide free artemisinin-based combination therapie... poor children suspected of having malaria. This q...red to determine if it reduces the number of Afric...
Breaking Medicine News(10 mins):Health News:This Holiday Season EyeCare America Asks Seniors, 'Do you see what I see?' 2Health News:This Holiday Season EyeCare America Asks Seniors, 'Do you see what I see?' 3Health News:SouthEast Alaska Regional Health Consortium Selects Orion Health's Rhapsody Integration Engine for Full-scale Application Integration and Monitoring 2Health News:SouthEast Alaska Regional Health Consortium Selects Orion Health's Rhapsody Integration Engine for Full-scale Application Integration and Monitoring 3Health News:Liberty Mutual and Holly Robinson Peete Team Up to Remind Families to Be Fire Smart this Holiday Season with Tips on Fire Safety 2Health News:Liberty Mutual and Holly Robinson Peete Team Up to Remind Families to Be Fire Smart this Holiday Season with Tips on Fire Safety 3Health News:Liberty Mutual and Holly Robinson Peete Team Up to Remind Families to Be Fire Smart this Holiday Season with Tips on Fire Safety 4Health News:Canada Supports Ground-Breaking Malaria Treatment Program in Sub-Saharan Africa 2Health News:Canada Supports Ground-Breaking Malaria Treatment Program in Sub-Saharan Africa 3
...new study in the August issue of The Journal of Pe...t behavior at schools may have underlying learning...Rappaport, a child psychiatrist at Cambridge Healt...d University conducted a study on 33 students in o...
...e Beijing Health Bureau confirmed on Friday the de... About 3,142 HIV carriers and AIDS patients were l...g according to Statistics from the Beijing Health ... discovered in the first six months of the year. ...
...e mechanism of how high-fiber foods really work in...the Medical College of Georgia. Their study reveal...lls thereby releasing the lubricating mucus. Dr. ...dical College of Georgia and corresponding author ...
...novel study intending to gauge the efficacy of smo...arms may not be able to alert the elderly. The res...f 65 to 85 found that a mixed frequency signal sho...h frequency signal, which most smoke alarms use. ...
Other Medicine News:Health News:What does High-fiber Foods Really do? 2
(Date:11/26/2008)... , FRANKLIN, Mass., Nov. 26 /PRNewswire-Firs...CSF) announced today that it has received full app...FDA) for its U.S. pivotal trial to study the effec...nd associated therapy in the prevention of Contras...so approved PLC,s request to expand their investig...
(Date:11/25/2008)...ire-USNewswire/ -- Kleinert Kutz and University o...S. hand transplant on Messina, New York resident, ...al Hand Care Center on Monday, November 24. The i...leted shortly after 9 p.m. in a record nine hours....in/prnh/20081125/DC48555-a ) , (Photo: http:/...
(Date:11/25/2008)... 25 Proteolix, Inc., a,leader in ...s that target,protein degradation pathways in can... data from two ongoing Phase 2 clinical trials of ... at the upcoming 50th Annual Meeting of the,Ameri...he first in a new class,of specific proteasome in...
(Date:11/25/2008)...swire-FirstCall/ -- Pharmacyclics, Inc.,(Nasdaq: ...leted a Phase 1,clinical trial with PCI-27483, th...Factor VIIa inhibitor. The trial was conducted in ...afety and pharmacologic effect of,PCI-27483. A si...ear dose,response in the International Normalized...
Breaking Medicine Technology:PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 3PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 4Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 2Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 3Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 2Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 2Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 4Siemens Soarian Health Information Management is Widely Adopted by Leading Healthcare Institutions in 2007 3089 1Siemens Soarian Health Information Management is Widely Adopted by Leading Healthcare Institutions in 2007 3089 2Siemens Soarian Health Information Management is Widely Adopted by Leading Healthcare Institutions in 2007 3089 3Siemens Soarian Health Information Management is Widely Adopted by Leading Healthcare Institutions in 2007 3089 4Consumer Safety Alert on Fat Dissolving Injections 3086 1Consumer Safety Alert on Fat Dissolving Injections 3086 2Consumer Safety Alert on Fat Dissolving Injections 3086 3N V Perricone M D Cosmeceuticals Elevates Role of Christina Banas to Executive Director Global Communications 3083 1N V Perricone M D Cosmeceuticals Elevates Role of Christina Banas to Executive Director Global Communications 3083 2Anaptys Biosciences Appoints R Scott Greer to Board of Directors 1119 1Anaptys Biosciences Appoints R Scott Greer to Board of Directors 1119 2
...-May 10, 2007 - According to,The Waismann Method 2...respondents seeking treatment for opiate dependenc...icodin, OxyContin, Percocet,and Fentanyl were amon...mothers who reported a dependency said they suffer...egistered addiction,specialist for the Waismann Me...
...oping Therapies to Prevent,and Reverse Atheroscler...07 /PRNewswire/ -- KineMed, Inc.,a pathway-based ...today the first method for measuring the efflux of...athway known as reverse cholesterol,transport (RCT...,cholesterol can be removed from tissues and has t...
Other Medicine Technology:Waismann Method Survey Reveals 65 Percent of Women Seeking Opiate,Dependency Treatment Are Mothers 2KineMed Presents Data Measuring Changes in Reverse Cholesterol,Transport for the First Time 2KineMed Presents Data Measuring Changes in Reverse Cholesterol,Transport for the First Time 3
Set of 5 large bone curettes. One each of the following: angled small, straight small, angled medium, straight medium, and angled large.
Rasp with down cutting pattern.
Designed for proximal femoral elevation in total hip replacement or in other surgery with a similar need for bone manipulation.
Beuse Zygomatic Arch Awl with slightly curved tip.
Medicine Products: